Literature DB >> 11682055

A non-natural amino acid for efficient incorporation into proteins as a sensitive fluorescent probe.

M Taki1, T Hohsaka, H Murakami, K Taira, M Sisido.   

Abstract

A small and highly fluorescent non-natural amino acid that contains an anthraniloyl group (atnDap) was incorporated into various positions of streptavidin. The positions were directed by a CGGG/CCCG four-base codon/anticodon pair. The non-natural mutants were obtained in excellent yields and some of them retained strong biotin-binding activity. The fluorescence wavelength as well as the intensity of the anthraniloyl group at position 120 were sensitive to biotin binding. These unique properties indicate that the atnDap is the most suitable non-natural amino acid for a position-specific fluorescent labeling of proteins that is highly sensitive to microenvironmental changes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682055     DOI: 10.1016/s0014-5793(01)02935-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.

Authors:  Maithé Corbani; Miguel Trueba; Stoytcho Stoev; Brigitte Murat; Julie Mion; Véra Boulay; Gilles Guillon; Maurice Manning
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

Review 2.  Utility and considerations of donor-donor energy migration as a fluorescence method for exploring protein structure-function.

Authors:  Stanislav Kalinin; Lennart B A Johansson
Journal:  J Fluoresc       Date:  2004-11       Impact factor: 2.217

3.  Synthesis of the fluorescent amino acid rac-(7-hydroxycoumarin-4-yl)ethylglycine.

Authors:  Manfred Braun; Torsten Dittrich
Journal:  Beilstein J Org Chem       Date:  2010-06-24       Impact factor: 2.883

4.  Fluorescent mu selective opioid ligands from a mixture based cyclic peptide library.

Authors:  Yangmei Li; Colette T Dooley; Jaime A Misler; Ginamarie Debevec; Marc A Giulianotti; Margaret E Cazares; Laura Maida; Richard A Houghten
Journal:  ACS Comb Sci       Date:  2012-11-08       Impact factor: 3.784

Review 5.  Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.

Authors:  M Manning; A Misicka; A Olma; K Bankowski; S Stoev; B Chini; T Durroux; B Mouillac; M Corbani; G Guillon
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.